Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined...
Reexamination Certificate
2005-07-21
2009-12-29
Li, Q. Janice (Department: 1633)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
C435S325000, C424S093100
Reexamination Certificate
active
07638141
ABSTRACT:
A method of collecting embryonic-like stem cells from a placenta which has been treated to remove residual cord blood by perfusing the drained placenta with an anticoagulant solution to flush out residual cells, collecting the residual cells and perfusion liquid from the drained placenta, and separating the embryonic-like cells from the residual cells and perfusion liquid. Exogenous cells can be propagated in the placental bioreactor and bioactive molecules collected therefrom.
REFERENCES:
patent: 3862002 (1975-01-01), Sanders
patent: 5004681 (1991-04-01), Boyse et al.
patent: 5192553 (1993-03-01), Boyse et al.
patent: 5372581 (1994-12-01), Anderson
patent: 5415665 (1995-05-01), Hessel et al.
patent: 5635387 (1997-06-01), Fei et al.
patent: 5665557 (1997-09-01), Murray et al.
patent: 5670351 (1997-09-01), Emerson et al.
patent: 5827735 (1998-10-01), Young et al.
patent: 5874301 (1999-02-01), Keller et al.
patent: 5879318 (1999-03-01), Van der Heiden et al.
patent: 5905041 (1999-05-01), Beug et al.
patent: 5914108 (1999-06-01), Tsukamoto et al.
patent: 5914268 (1999-06-01), Keller et al.
patent: 5916202 (1999-06-01), Haswqell
patent: 5919176 (1999-07-01), Kuypers et al.
patent: 5928214 (1999-07-01), Rubinstein et al.
patent: 5993429 (1999-11-01), Kuypers et al.
patent: 6030836 (2000-02-01), Thiede et al.
patent: 6059968 (2000-05-01), Wolf, Jr.
patent: 6110739 (2000-08-01), Keller et al.
patent: 6179819 (2001-01-01), Haswell
patent: 6190368 (2001-02-01), Kuypers et al.
patent: 6255112 (2001-07-01), Thiede et al.
patent: 6461645 (2002-10-01), Boyse et al.
patent: 7045148 (2006-05-01), Hariri
patent: 2002/0132343 (2002-09-01), Lum
patent: WO 00/17325 (2000-03-01), None
patent: WO00/73421 (2000-12-01), None
patent: PCT/US00/26225 (2001-03-01), None
Erices et al., Brit J Haematol 2000;109:235-42.
Muhlemann et al, Placenta 1995;16:367-73.
Devlin et al. J Clin Endocrinol Metab 1985:60:880-5.
Contractor et al., A comparison of the effects of different perfusion regimes on the structure of the isolated human placental lobule. Cell Tissue Res. 237:609-617 (1984).
Hatzopoulos et al., “Isolation and characterization of endothelial progenitor cells from mouse embryos”, Development 125:1457-1468 (1998).
Moore et al., “A simple perfusion technique for isolation of maternal intervillous blood mononuclear cells from human placentae”, J. Immunol. Methods 209:93-104 (1997).
Shamblott et al., “Derivation of pluripotent stem cells from cultured human primordial germ cells”, Proc. Natl. Acad. Sci. U S A. 95:13726-13731 (1998). Erratum in: Proc. Natl. Acad. Sci. U S A 96: 1162 (1999).
Thompson et al., “Embryonic stem cell lines derived from human blastocysts”, Science 282:1145-1147 (1998); Erratum in: Science 282:1827 (1998).
Turner et al., “A modified harvest technique for cord blood hematopoietic stem cells”, Bone Marrow Transplant. 10:89-91 (1992).
Wang et al., “ Enhanced recovery of hematopoietic progenitor and stem cells from cultivated postpartum human placenta”, Blood 98(11/1):183a, abstract No. 769 (2001).
Ye et al., “Recovery of placental-derived adherent cells with mesenchymal stem cell characteristics”, Blood 98(11/1):147b, abstract No. 4260 (2001).
Myllynen, In Search of Models for Hepatic and Placental Pharmacokinetics, dissertation, University of Oulu (2003).
van Bekkurn, “The Pluripotent Hemopoietic Stem Cell: Its Identification and Applications,”Verh. Dtsch. Ges. Pathol.74:19-24 (1990).
Caplan, “The Mesengenic Process,”Clin. Plast. Surg.21(3):429-435 (1994)).
Expansion of human cord blood CD34+CD38− cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function(Blood, vol. 95, No. 1, p. 102-110, Jan. 2000)C. Dorrell.
Ex Vivo Expansion of Hematopoietic Precursors, Progenitors, and Stem Cells: The Next Generation of Cellular Therapeutics (Blood, vol. 87, No. 8, p. 3082-3088 (Apr. 1996)) Stephen G. Emerson.
Ex Vivo Expansionof Hematopoietic Stem and Progenitor Cells: Are We There Yet? (The Journal of Hematotherapy, vol. 8, p. 93-102 (1999)) Srour, et al.
Anthrogenesis Corporation
Jones Day
Li Q. Janice
LandOfFree
Isolated placental perfusate and placental cells isolated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated placental perfusate and placental cells isolated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated placental perfusate and placental cells isolated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4078392